River & Mercantile Asset Management LLP Novo Cure LTD Transaction History

River & Mercantile Asset Management LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 27, 2019	BUY	$42.22 - $63.23 $2.28 Million - $3.42 Million	54,020 New	54,020 $3.42 Million
Q4 2017 Feb 07, 2018	SELL	$16.3 - $21.9 $1.46 Million - $1.96 Million	-89,451 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$18.05 - $21.75 $1.61 Million - $1.95 Million	89,451	89,451 $1.78 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of River & Mercantile Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on River & Mercantile Asset Management LLP with notifications on news.